Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Breast Cancer
•
Radiation Oncology
Would you offer breast conserving therapy in a patient with breast cancer and Buerger's disease of the breast?
Would you offer breast conserving therapy or recommend mastectomy for an early stage breast cancer?
Related Questions
In which scenarios do you stage breast cancer using CT and nuclear bone scans versus PET-CT?
Have you seen any increased dermatologic toxicity with whole breast or chest wall radiation if patients have received recent or concurrent pembrolizumab?
Would you offer PMRT when the only indication is a focally positive margin?
What dose constraints do you when treating a patient with bilateral breast cancers with RNI?
Would you offer reirradiation for a patient who had prior MammoSite PBI?
Do you offer ultra-hypofractionated 5-fraction whole breast RT after oncoplastic rearrangement?
What treatment would you recommend for DCIS incidentally found in pathologic specimen following breast reduction surgery?
What pentoxifylline and vitamin E dose do you typically use for both the prevention and treatment of radiation-associated fibrosis after breast RT?
In the setting of recurrent breast cancer localized to the chest wall (no prior RT), do you allow concurrent abemaciclib or Enhertu with post-operative comprehensive chest wall irradiation?
In the era of hypofractionation for breast cancer, how would you re-irradiate for these cases if recurrence develops years later?